Interferon induces up-regulation of Spi-1/PU.1 in human leukemia K562 cells

被引:10
|
作者
Gutierrez, P
Delgado, MD
Richard, C
MoreauGachelin, F
Leon, J
机构
[1] UNIV CANTABRIA,DEPT BIOL MOL,SANTANDER 39011,SPAIN
[2] HOSP UNIV MARQUES DE VALDECILLA,SERV HEMATOL,SANTANDER,SPAIN
[3] INST CURIE,INSERM,U248,PARIS,FRANCE
关键词
D O I
10.1006/bbrc.1997.7760
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human K562 cell line is derived from a chronic myelogenous leukemia in blastic crisis. Treatment of K562 cells with interferons alpha, beta or gamma resulted in inhibition of cell proliferation. Spi-1/PU.1 is a transcription factor of the Ets family which is required for normal hematopoyesis. We have found that spi-1 mRNA and protein as well as Spi-1-DNA binding activity increase after exposure of K562 cells to interferons. The increase in spi-1 expression ranged from 4- to 8-fold with the different interferons. K562 cells can be differentiated in vitro towards erythroid cells or monocyte-macrophage cells. Interestingly, the regulation of spi-1 by interferon-alpha depended on the differentiated phenotype of K562 cells: interferon-alpha failed to induce spi-1 in erythroid differentiated cells, whereas it induced spi-1 in monocyte-macrophage differentiated cells. The results suggest a role for Spi-1 in the cytostatic response to interferons. (C) 1997 Academic Press.
引用
收藏
页码:862 / 868
页数:7
相关论文
共 50 条
  • [1] Spi-1/PU.1 proto-oncogene induces opposite effects on monocytic and erythroid differentiation of K562 cells
    Delgado, MD
    Gutiérrez, P
    Richard, C
    Cuadrado, MA
    Moreau-Gachelin, F
    León, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 252 (02) : 383 - 391
  • [2] PU.1 (SPI-1) expression in human acute leukemia
    Voso, MT
    Chiusolo, P
    Hohaus, S
    Serra, FG
    Sica, S
    Piccirillo, N
    Tenen, DG
    Leone, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 144 - 144
  • [3] Correlation of PU.1 and signal regulatory protein α1 expression in PU.1 transgenic K562 cells
    Iseki, Yuko
    Nakahara, Masako
    Kubo, Makoto
    Obata, Fumiya
    Harigae, Hideo
    Takahashi, Shinichiro
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 29 (02) : 319 - 323
  • [4] PU.1 (SPI-1) AUTOREGULATES ITS EXPRESSION IN MYELOID CELLS
    CHEN, HM
    RAYGALLET, D
    ZHANG, P
    HETHERINGTON, CJ
    GONZALEZ, DA
    ZHANG, DE
    MOREAUGACHELIN, F
    TENEN, DG
    ONCOGENE, 1995, 11 (08) : 1549 - 1560
  • [5] SPI-1/PU.1 - AN ONCOGENE OF THE ETS FAMILY
    MOREAUGACHELIN, F
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (2-3): : 149 - 163
  • [6] The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages
    Lloberas, J
    Soler, C
    Celada, A
    IMMUNOLOGY TODAY, 1999, 20 (04): : 184 - 189
  • [7] THE PU.1 TRANSCRIPTION FACTOR IS THE PRODUCT OF THE PUTATIVE ONCOGENE SPI-1
    GOEBL, MG
    CELL, 1990, 61 (07) : 1165 - 1166
  • [8] Differential Regulation of Primitive Myelopoiesis in the Zebrafish by Spi-1/Pu.1 and C/ebp1
    Su, Fengyun
    Juarez, Marianne A.
    Cooke, Christopher L.
    LaPointe, Lisa
    Shavit, Jordan A.
    Yamaoka, Jennifer S.
    Lyons, Susan E.
    ZEBRAFISH, 2007, 4 (03) : 187 - 199
  • [9] Spi-1/PU.1 transgenic mice develop multistep erythroleukemias
    MoreauGachelin, F
    Wendling, F
    Molina, T
    Denis, N
    Titeux, M
    Grimber, G
    Briand, P
    Vainchenker, W
    Tavitian, A
    MOLECULAR AND CELLULAR BIOLOGY, 1996, 16 (05) : 2453 - 2463
  • [10] THE PU.1/SPI-1 PROTOONCOGENE IS A TRANSCRIPTIONAL REGULATOR OF A LENTIVIRUS PROMOTER
    CARVALHO, M
    DERSE, D
    JOURNAL OF VIROLOGY, 1993, 67 (07) : 3885 - 3890